iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression
Lucie Portier(Institut de Radioprotection et de Sûreté Nucléaire), Frank Griscelli(Inserm)
Cited by 19
Related Papers
Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential
|bioRxiv (Cold Spring Harbor Laboratory)|2020|3